Record details

This document is also available in the following languages:

General Information

Country

Germany

Title of risk assessment

6786-01-0057 (adv. 42010.0057); Summary of the risk assessment of a deliberate release (field trial) of genetically modified oilseed rape (Brassica napus L.), different independend lines with an altered storage lipid composition, issued by the German Competent Authority

Date of the risk assessment

1997-03-27

Competent National Authority(ies) responsible for the risk assessment

Record #12096

Federal Office of Consumer Protection and Food Safety

Mauerstrasse 39-42

Berlin

Germany, 10117

Phone:	+49-(0)3018-445-6500
Fax:	+49-(0)3018-445-6099
Email:	german_bch@bvl.bund.de
Url:	http://www.biosafety-bch.de (english language),BVL Homepage (English)

Risk assessment details

Living modified organism

Record #101385

Brassica napus modified for altered fatty acid metabolism

BAZ Changes in quality and/or metabolite content - Lipid and fatty acids Resistance to antibiotics - Kanamycin

Record #110919

Oilseed rape modified for an altered fatty acid metabolism in the seeds

DSV Changes in quality and/or metabolite content - Lipid and fatty acids Resistance to antibiotics - Kanamycin

Record #110940

Oilseed rape modified for increased myristic acid content in the seeds

DSV Changes in quality and/or metabolite content - Lipid and fatty acids Resistance to antibiotics - Kanamycin

Record #110922

Oilseed rape modified for increased oleic acid content in the seeds

DSV Changes in quality and/or metabolite content - Lipid and fatty acids Resistance to antibiotics - Kanamycin

Scope of the risk assessment

LMOs for Introduction into the environment
- Field trial

Risk assessment report / Summary

6786-01-0057 (bzw. 42010.0057); Zusammenfassung der Risikobewertung eines Freisetzungsvorhabens (Feldversuch) mit gentechnisch veränderten Rapspflanzen (Brassica napus L.), verschiedene unabhängige Linien mit veränderter Lipidzusammensetzung, erstellt durch die deutsche zuständige Behörde

Methodology and points to consider

Potential adverse effects identified in the risk assessment

The execution of this field trial is not expected to have a negative impact on human or animal health, or on the environment.

Estimation of the overall risk

Adverse effects on human or animal health or on the environment are not expected.

Receiving environment(s) considered

1 field site in Germany, for details refer to the German LMO/GMO location register ( https://apps2.bvl.bund.de/stareg_web/localeSwitch.do?language=en&page=/showflaechen.do?)

LMO detection and identification methods proposed

construct specific PCR-based method

Additional Information

- deliberate release, no placing on the market.
- crops are not intended to be used as food or feed.

- There is no Summary Notification Information Format available on the Internet (WebSNIF) for B/DE/97/57

Other relevant website address or attached documents

EN		BVL database on field trials in Germany (German language only)
DE		BVL-Datenbank zu Freisetzungsvorhaben in Deutschland

EN		BVL German LMO/GMO location register
DE		Deutsches GVO-Standortregister des BVL